EyePoint Pharmaceuticals Statistics
Total Valuation
EYPT has a market cap or net worth of $1.09 billion. The enterprise value is $906.65 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EYPT has 82.79 million shares outstanding. The number of shares has increased by 35.36% in one year.
| Current Share Class | 82.79M |
| Shares Outstanding | 82.79M |
| Shares Change (YoY) | +35.36% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 60.63% |
| Float | 61.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.29 |
| Forward PS | 153.68 |
| PB Ratio | 4.56 |
| P/TBV Ratio | 5.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 21.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.18, with a Debt / Equity ratio of 0.12.
| Current Ratio | 7.18 |
| Quick Ratio | 6.81 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15,594.86 |
Financial Efficiency
Return on equity (ROE) is -98.23% and return on invested capital (ROIC) is -58.65%.
| Return on Equity (ROE) | -98.23% |
| Return on Assets (ROA) | -49.39% |
| Return on Invested Capital (ROIC) | -58.65% |
| Return on Capital Employed (ROCE) | -98.52% |
| Revenue Per Employee | $256,600 |
| Profits Per Employee | -$1.25M |
| Employee Count | 165 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 82.88 |
Taxes
In the past 12 months, EYPT has paid $183,000 in taxes.
| Income Tax | 183,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +43.24% in the last 52 weeks. The beta is 1.69, so EYPT's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | +43.24% |
| 50-Day Moving Average | 12.75 |
| 200-Day Moving Average | 9.21 |
| Relative Strength Index (RSI) | 58.82 |
| Average Volume (20 Days) | 1,366,461 |
Short Selling Information
The latest short interest is 7.56 million, so 9.13% of the outstanding shares have been sold short.
| Short Interest | 7.56M |
| Short Previous Month | 8.13M |
| Short % of Shares Out | 9.13% |
| Short % of Float | 12.21% |
| Short Ratio (days to cover) | 5.19 |
Income Statement
In the last 12 months, EYPT had revenue of $42.34 million and -$205.75 million in losses. Loss per share was -$3.00.
| Revenue | 42.34M |
| Gross Profit | -161.42M |
| Operating Income | -218.33M |
| Pretax Income | -205.57M |
| Net Income | -205.75M |
| EBITDA | -216.25M |
| EBIT | -218.33M |
| Loss Per Share | -$3.00 |
Full Income StatementBalance Sheet
The company has $204.02 million in cash and $23.26 million in debt, giving a net cash position of $180.76 million or $2.18 per share.
| Cash & Cash Equivalents | 204.02M |
| Total Debt | 23.26M |
| Net Cash | 180.76M |
| Net Cash Per Share | $2.18 |
| Equity (Book Value) | 200.18M |
| Book Value Per Share | 2.88 |
| Working Capital | 186.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$210.91 million and capital expenditures -$2.68 million, giving a free cash flow of -$213.59 million.
| Operating Cash Flow | -210.91M |
| Capital Expenditures | -2.68M |
| Free Cash Flow | -213.59M |
| FCF Per Share | -$2.58 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -515.67% |
| Pretax Margin | -485.53% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EYPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.36% |
| Shareholder Yield | -35.36% |
| Earnings Yield | -18.92% |
| FCF Yield | -19.64% |
Analyst Forecast
The average price target for EYPT is $29.60, which is 125.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $29.60 |
| Price Target Difference | 125.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 63.06% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
EYPT has an Altman Z-Score of -0.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.7 |
| Piotroski F-Score | 1 |
